| 000 | 01305 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515001208.0 | ||
| 264 | 0 | _c20051213 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a0028-2685 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeltl, D | |
| 245 | 0 | 0 |
_aPost-treatment plasma transforming growth factor beta 1 (TGF-beta1) level predicts for late morbidity in patients with advanced head and neck cancer. _h[electronic resource] |
| 260 |
_bNeoplasma _c2005 |
||
| 300 |
_a393-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms, Squamous Cell _xblood |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadiotherapy |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xanalysis |
| 650 | 0 | 4 | _aTransforming Growth Factor beta1 |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 700 | 1 | _aZávadová, E | |
| 700 | 1 | _aPála, M | |
| 700 | 1 | _aHozák, P | |
| 773 | 0 |
_tNeoplasma _gvol. 52 _gno. 5 _gp. 393-7 |
|
| 999 |
_c15785981 _d15785981 |
||